IDiyas

For the Inventor, By the Inventor

St. Louis, MO, United States of America

William F Vernier

USPTO Granted Patents = 39

Average Co-Inventor Count = 16.2

ph-index = 8

Forward Citations = 205(Granted Patents)


Location History:

  • St. Louis, MI (US) (2004)
  • Oceanside, CA (US) (2005)
  • Saint Louis, MO (US) (2006 - 2007)
  • St. Louis, MO (US) (2002 - 2010)

Company Filing History:

goldMedal21 out of 200 
 
Pharmacia Corporation
 patents
silverMedal12 out of 1,323 
 
G.d. Searle & Company
 patents
bronzeMedal5 out of 4,455 
 
Pfizer Corporation
 patents
4. 1 out of 1 
 
Pharmacia Corporation Global Patent Department
 patent

Years Active: 2002-2010

Loading Chart...
39 patents (USPTO):Explore Patents
1. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2010-04-20),
2. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2007-08-07),
3. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2006-10-17),
4. 7119203 - Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors (2006-10-10),
5. 6909001 - Method of making tricyclic aminocyanopyridine compounds (2005-06-21),
6. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-10-12),
7. 6765023 - Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-07-20),
8. 6750233 - Aromatic sulfone hydroxamic acid metalloprotease inhibitor (2004-06-15),
9. 6750228 - Aromatic sulfone hydroxamic acid metalloprotease inhibitor (2004-06-15),
10. 6723753 - Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),
11. 6723752 - (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),
12. 6710089 - Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-23),
13. 6699898 - Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-02),
14. 6696472 - Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),
15. 6696435 - Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

Title: The Legacy of William F. Vernier, an Inventor from St. Louis

Introduction: William F. Vernier, a distinguished inventor hailing from St. Louis, Missouri, has made significant contributions to the world of innovation through his groundbreaking work in various fields.

Latest Patents: William F. Vernier's latest patents include cutting-edge technologies in the automotive industry, particularly focusing on advancements in electric vehicle components and safety features.

Career Highlights: Throughout his illustrious career, William F. Vernier has been recognized for his pioneering spirit and inventive mindset, leading to the development of revolutionary solutions that have reshaped industries.

Collaborations: William F. Vernier has collaborated with leading research institutions and automotive companies to bring his visionary ideas to life, fostering a culture of innovation and progress in the field.

Conclusion: William F. Vernier's dedication to pushing the boundaries of what is possible through his inventions has solidified his reputation as a trailblazer in the world of innovation, leaving a lasting impact for generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…